Treatment for Patient and Family Engagement

Phase-Based Estimates
Intermountain Medical Center, Murray, UT
All Sexes
Eligible conditions
Patient and Family Engagement

Study Summary

This study is evaluating whether inviting family members to remain in a patient's room during ICU procedures will improve patient & family engagement and improve long term psychological outcomes after an ICU admission.

See full description

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 6 secondary outcomes in patients with Patient and Family Engagement. Measurement will happen over the course of Through 7 days after the ICU procedure.

Month 3
Patient & Family Member Anxiety & Depression
Patient & Family Member PTSD
Day 7
Procedural Complication Rate
Hour 24
Trainee Satisfaction with Procedure Education
Hour 48
Clinician Stress
Patient & Family Member Engagement
Patient & Family Member Stress

Trial Safety

Trial Design

2 Treatment Groups

Families Excluded From Presence at Procedures
Placebo group

This trial requires 120 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.

Families Excluded From Presence at Procedures
Families not invited to remain for ICU procedures
Families Invited to Be Present at Procedures
Families invited to remain for ICU procedures

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months after icu procedure
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 3 months after icu procedure for reporting.

Who is running the study

Principal Investigator
S. B.
Sarah Beesley, Pulmonologist - Shock Trauma ICU
Intermountain Health Care, Inc.

Closest Location

Intermountain Medical Center - Murray, UT

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
18 years old or older
Able to read & speak English
Physician (both attending physicians and trainees) and nurses who work in the ICU during the study period.
Family member of a patient or a patient that has undergone one of these procedures at any point during the ICU stay (if the procedure occurs from Sunday at 8 am to Friday at 12 pm): intubation, central line placement, arterial line placement, bronchoscopy, thoracentesis, chest tube placement, paracentesis and lumbar puncture

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is patient and family engagement?

Add answer

We believe many people do not recognize or engage adequately with the health team, including the patient and family. We provide a brief conceptual framework that might help health providers to think about the relationship with patients and families more systematically including the impact on patients' and families' experiences, perceptions, knowledge and views and the ways that these affect the ability of health professionals and institutions to deliver effective, empathetic and client-centered care.

Unverified Answer

What are common treatments for patient and family engagement?

Add answer

There is a lack of data in the clinical trials on patient and family engagement. Recommendations for improving the quality of clinical trials in this area include providing information that allows patients to make informed choices of trial interventions, engaging patients and their families to assist in this decision-making process, providing tools to assist patients and families to make informed choices of trial interventions, and optimizing clinical trial design such that studies allow a more informed consumer of the outcomes and potential benefits of trial treatments.

Unverified Answer

Can patient and family engagement be cured?

Add answer

In our experience, the most salient factors of poor engagement with the medical care are lack of patient-specific information-giving systems, lack of consultation time, and lack of continuity of care. We believe patient and family engagement in clinical trials can be improved with the use of tools such as a comprehensive and easily accessible medical record with patient-centric information-giving and consultation times, information about drug/therapy options, and options for communication with clinical trial staff.

Unverified Answer

What causes patient and family engagement?

Add answer

If clinicians are to deliver their best patient-centred outcomes, they need to focus on patients and families to ensure that everyone's needs are met and family members' needs are considered.

Unverified Answer

What are the signs of patient and family engagement?

Add answer

The signs are as follows: engagement with clinical team, engagement with treatment processes, family involvement with clinical care, patient and family engagement with professional services and patient and family engagement in follow-ups.

Unverified Answer

How many people get patient and family engagement a year in the United States?

Add answer

Despite the growing body of evidence suggesting that the quality of healthcare and patient and family engagement are highly interdependent, the national performance of measures to monitor and inform clinicians and patients about family engagement remains poor.

Unverified Answer

How does treatment work?

Add answer

The treatment for childhood cancer in Canada depends on factors that vary between patients, families, and institutions. Most children are treated in pediatric oncology departments and at PICUs. Children and families are involved in treatment decision making from a young age.

Unverified Answer

What are the latest developments in treatment for therapeutic use?

Add answer

The recent advancements or developments in therapeutic strategies have allowed for the treatment of this disease in the last 2 decades. Although treatment remains controversial because it is only supported by prospective studies, we [have demonstrated that new treatment regimens may prolong OS in high-risk stage IIIA patients. The new treatment regimen is composed of new therapeutic strategies added with surgery that can achieve more efficient resection, which leads to better prognosis and better OS, as well as chemotherapy.

Unverified Answer

How serious can patient and family engagement be?

Add answer

If a patient or caregiver wishes to engage in a clinical trial, but does not know if their wishes are in keeping with the study protocol, they need to be informed of their possibilities. A well-informed patient may make an informed decision and be better able to participate. A patient, however, does not necessarily want to participate if they are unhappy, feel that the trial is a risk to their well-being, feel that the trial is too burdensome, or feel too uncomfortable with being in the hospital. The burden/stress imposed upon the patient should help the doctor gauge their interest and determine the likelihood of their engagement in the trial.

Unverified Answer

Does patient and family engagement run in families?

Add answer

Having an active family role in care was linked to greater satisfaction with care. This relationship was particularly salient for parents of young or frail adults. This suggests the importance of family involvement, in the context of enhanced primary care, for improving the health outcomes for individuals and their families.

Unverified Answer

What are the common side effects of treatment?

Add answer

Most side effects are not specific to cannabidiol, except for sleep. Symptoms worsened with long-term use. The most common side effects when not taking cannabidiol are: agitation/aggression; headache; constipation; and dizziness. Side effects were generally milder when using a CBD-containing preparation than when using the CBD/THC preparation, except for sleep, which was mildly more severe with THM/CBD than with THC.

Unverified Answer

Who should consider clinical trials for patient and family engagement?

Add answer

The most salient findings for recruiting patients and families into clinical trials were that trials should: (1) provide adequate family education and support by the trial team (2) empower the patient/family and make them more positive about the trial (3) emphasize the patient's and family's role in treatment decision making. The most common barriers to patient and family involvement were that trials do not provide sufficient incentives and barriers to participation. Overall, a concerted effort from all parties is needed to make clinical trial participation more available to patients and families.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Patient and Family Engagement by sharing your contact details with the study coordinator.